World Pharma News


TakedaLocated in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website,

Takeda RSS Channel

Display # 
Title Published Date
Takeda establishes new trading company and reinforces business structure in China 22 January 2013
Takeda's exclusive distribution of Pfizer products in Japan 18 June 2012
Takeda to Acquire URL Pharma 12 April 2012
Open-source drug research consortium draws a major new champion 05 April 2012
New Structure of Business Operations for a Global Pharmaceutical Company 06 November 2011
Takeda completes acquisition and names new CEO of Nycomed 30 September 2011
Takeda to Acquire Nycomed - Transaction will Transform Takeda's Global Business 19 May 2011
Takeda to Establish Four Sales and Marketing Subsidiaries 05 October 2009
Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filing in Europe 11 June 2009
Takeda to Sponsor Berlin Marathon 2007 29 September 2007
Lundbeck and Takeda form Alliance to Develop and Commercialize a Portfolio of Novel Compounds 18 September 2007
Takeda's Investigational Compound TAK-536 Enters into Phase 2 Clinical Stage in Japan 03 September 2007

© World Pharma News 2006 - 2015

Top Desktop version